Patents
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
09/2009
09/10/2009US20090227635 Therapeutic compounds
09/10/2009US20090227616 Inhibitors of akt activity
09/10/2009US20090227592 Compounds effecting glucokinase
09/10/2009US20090227585 Substituted n-heterocycle derivatives and methods of their use
09/10/2009US20090227558 Amino-derivatives as novel inhibitors of histone deacetylase
09/10/2009US20090227557 Substituted beta-lactams
09/09/2009EP2098520A1 Photochromic dichroic naphtho-pyrans and optical articles containing them
09/09/2009EP2098508A1 Cyclic derivatives as modulators of chemokine receptor activity
09/09/2009EP2097408A1 Improved process for eprosartan
09/09/2009EP2097405A2 Anti-viral compounds
09/09/2009EP2097395A1 Process for the preparation of valsartan and intermediate products
09/09/2009EP2097382A1 Heteroaryl-substituted carboxamides and use thereof for the stimulation of the expression of no synthase
09/09/2009EP1893197B1 Chromane substituted benzimidazole derivatives as acid pump antagonists
09/09/2009EP1449833B1 Bisimide compound, acid generator and resist composition each containing the same, and method of forming pattern from the composition
09/09/2009EP1379243B1 Methods for treating metabolic diseases using malonyl-coa decarboxylase inhibitors
09/09/2009CN101528728A 6-1H-imidazo-quinazoline and quinolines derivatives, new potent analgesics and anti-inflammatory agents
09/09/2009CN101525393A Oxime ester photoinitiator and preparation method thereof
09/09/2009CN101525334A Organic solar cell material and preparation thereof
09/09/2009CN101525333A Synthesis method of metixene hydrochloride
09/09/2009CN100537566C Organic dye, its production and use
09/09/2009CN100537527C Aryl and biaryl compounds having MCH modulatory activity
09/08/2009US7585888 Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders
09/08/2009US7585878 2-[(2,5-dimethylpyrrolidin-1-yl)methyl]-N-(1-methyl-2-oxo-1,2,3,4-tetrahydroquinolin-7-yl)biphenyl-4-carboxamide; capsaicin receptor VR1 inhibitory activity; inflammatory pain and neurogenic pain, migraine, cluster headache, bladder diseases including overactive bladder
09/08/2009US7585860 Substituted oxazolidinones and their use in the field of blood coagulation
09/08/2009US7585859 PDE4B inhibitors and uses therefor
09/08/2009US7585858 N-((4-((( 1R)-3 -(dimethylamino)-1-((phenylsulfanyl)methyl)propyl)amino)-3-nitrophenyl)sulfonyl)-4-(4-(2-fluorobenzyl)-4-methoxy-1-piperidinyl)benzenecarboximidamide; trigger apoptosis through the inhibition of the Bcl family of proteins
09/08/2009US7585853 Compounds having selective inhibiting effect at GSK3
09/08/2009CA2440931C Hiv protease inhibitors based on amino acid derivatives
09/08/2009CA2387351C Indole derivatives as tyrosine kinase inhibitors
09/08/2009CA2373665C Substituted thienocycloalk(en)ylamino-1,3,5-triazine
09/08/2009CA2342739C Azetidine derivatives, preparation and medicines containing them
09/08/2009CA2316388C Tetrahydrobenzindole derivative
09/08/2009CA2213466C Inhibitors of microsomal triglyceride transfer protein and method
09/08/2009CA2141731C Antifungal agents, processes for the preparation thereof, and intermediates
09/03/2009WO2009107764A1 Composition for agricultural use for controlling or preventing plant diseases caused by plant pathogens
09/03/2009WO2009107391A1 Compound having 6-membered aromatic ring
09/03/2009WO2009107387A1 2-oxochromene derivative
09/03/2009WO2009106817A2 Compound
09/03/2009WO2009106586A1 Quinolines as inhibitors of farnesyl pyrophosphate synthase
09/03/2009WO2009106534A1 Novel heterocyclic carboxamides as m1 agonists
09/03/2009WO2009106470A2 Angiotensin ii receptor antagonists
09/03/2009WO2009106203A1 Glucokinase activators
09/03/2009WO2009105824A1 Methods of modulating the activity of the mc5 receptor and treatment of conditions related to this receptor
09/03/2009WO2009105823A1 3-aminoalkyl-1,4-diazepan-2-one melanocortin-5 receptor antagonists
09/03/2009WO2009070045A3 Imidazole derivatives, process for their preparation, and thier pharmaceutical use
09/03/2009WO2009058937A3 Heteroaryl ethers and processes for their preparation
09/03/2009US20090221661 Phosphodiesterase 4 inhibitors
09/03/2009US20090221643 4-phenyl-3-(2-propylsulfonylamino) tetrahydrofuran derivatives which potentiate glutamate receptors and are useful in the treatment of schizophrenia
09/03/2009US20090221572 4,5,6,7-tetrahydrobenzo[b]thiophene derivatives and their use as sigma receptor ligands
09/03/2009US20090221564 Heterocyclic Compounds and Their Use in the Treatment of Cardiovascular Disease
09/03/2009US20090220662 Isosorbide derivatives and their use as flavor modifiers, tastants, and taste enhancers
09/03/2009US20090220454 Use of the histone deacetylase inhibitor N-hydroxy-4-[2-(3-dimethylaminobenzofuran-2-ylcarbonylamino)ethoxy]benzamide (aka CRA-24781, PCI-24781) for treating myelogenous leukemia (MML) or acute myelogenous leukemia (AML), optionally in combination therapy
09/03/2009CA2717011A1 Quinolines as inhibitors of farnesyl pyrophosphate synthase
09/03/2009CA2716898A1 Compound having 6-membered aromatic ring
09/03/2009CA2716647A1 Composition for agricultural use for controlling or preventing plant diseases caused by plant pathogens
09/03/2009CA2716599A1 Glucokinase activators
09/03/2009CA2716316A1 Methods of modulating the activity of the mc5 receptor and treatment of conditions related to this receptor
09/03/2009CA2716250A1 3-aminoalkyl-1,4-diazepan-2-one melanocortin-5 receptor antagonists
09/03/2009CA2714607A1 Hexahydrocyclopentyl[f]indazole carboxamides and derivatives thereof as selective glucocorticoid receptor modulators
09/03/2009CA2714058A1 2-aminoimidazole beta-secretase inhibitors for the treatment of alzheimer's disease
09/03/2009CA2712689A1 Angiotensin ii receptor antagonists
09/02/2009EP2096110A1 Acridane-9-dithiocarboxylate derivatives for generating chemiluminescence with a peroxidase
09/02/2009EP2096108A1 Novel organic electroluminescent compounds and organic electroluminscent device using the same
09/02/2009EP2094714A2 Substituted thienopyridone compounds with antibacterial activity
09/02/2009EP2094692A2 Modulators of glucocorticoid receptor, ap-1 and/or nf-kappab activity and use thereof
09/02/2009EP2094670A1 Heterocyclyc sulfonamides having edg-i antagonistic activity
09/02/2009EP2094659A1 Heteroaryl (substituted) alkyl n-substituted sulfoximines as insecticides
09/02/2009EP2094272A2 Nitrogen containing substituted heterocycles as platelet adp receptor inhibitors
09/02/2009EP1937672B1 N-[(4,5-diphenylpyrimidin-2-yl)methyl]amine derivatives, the preparation thereof and their therapeutic use
09/02/2009EP1909792B1 Substituted piperidine derivatives as somatostatin sst1 receptor antagonists
09/02/2009EP1899322B1 Isoquinoline derivatives as inhibitors of rho-kinase
09/02/2009EP1888574B1 New antibiotic derivatives
09/02/2009EP1572215B1 Benzo[d]azepine derivatives for the treatment of neurological disorders
09/02/2009EP1470137B1 Edg receptor agonists
09/02/2009EP1282617B1 Hydantoin derivatives with affinity for somatostatin receptors
09/02/2009CN101522669A Therapeutic lactams
09/02/2009CN101519403A Method for synthesis tioconazole
09/02/2009CN101519402A Thiochromone compound, synthetic method and application thereof in preparing antifungal medicaments
09/02/2009CN101519386A Large conductance calcium-activated K channel opener
09/02/2009CN100534990C Pyrrolidone carboxamides
09/01/2009US7582770 3-(2-{1-[(3-Cyclopentyl-1-methyl-2-pyridin-2-yl-1H-indole-6-carbonyl)amino]cyclobutyl}-1-methyl-1H-benzoimidazol-5-yl)acrylic acid; hepatitis C virus infection; synergistic with another inhibitor of HCV polymerase or immunomodulatory agent such as interferons
09/01/2009US7582765 Aryl aniline β2 adrenergic receptor agonists
09/01/2009US7582761 Vanilloid receptor ligands and their use in treatments
09/01/2009US7582669 Aminoindazole derivatives as medicaments and pharmaceutical compositions including them
09/01/2009US7582660 2-thio-substituted imidazole derivatives and their use in pharmaceutics
09/01/2009US7582658 Bicyclic compound
09/01/2009US7582657 Vanilloid receptor ligands and their use in treatments
09/01/2009US7582654 Antiarrhythmia agents, treating gastrointensinal disorder, gastroesophageal reflux, chronic obstructive pulmonary disease, diabetes;N-cotnaining heterocyclic compound with carbamate or amide groups and indazole ring
09/01/2009US7582645 Pyrimidine derivatives for treatment of hyperproliferative disorders
09/01/2009US7582644 Pyrimidyl sulphone amide derivatives as chemokine receptor modulators
09/01/2009US7582632 Tri(cyclo) substituted amide compounds
09/01/2009US7582627 3-aminoquinazolin-2,4-dione antibacterial agents
09/01/2009US7582624 Benzodiazepine derivatives and pharmaceutical compositions containing them
09/01/2009US7582589 3-carbonylaminothiophenes and their use as fungicides
09/01/2009CA2506491C Novel derivatives of pyrrolidines and thiazolidines, process for preparing them and pharmaceutical compositions containing them
09/01/2009CA2367368C Carbamic acid derivatives and their use as metabotropic glutamate receptor ligands
08/2009
08/27/2009WO2009105440A1 Beta-lactams for reducing intraocular pressure
08/27/2009WO2009105438A1 Therapeutic substituted lactams
08/27/2009WO2009104819A1 Benzodiazepine compound and pharmaceutical composition
08/27/2009WO2009104733A1 Organic electroluminescent device material and organic electroluminescent device